Preparation of 16β-Estradiol Derivative Libraries as Bisubstrate Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 Using the Multidetachable Sulfamate Linker

被引:9
|
作者
Berube, Marie
Delagoutte, Florian
Poirier, Donald [1 ]
机构
[1] CHU Laval, Res Ctr, CHUQ, Med Chem Lab, Quebec City, PQ G1V 4G2, Canada
来源
MOLECULES | 2010年 / 15卷 / 03期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Solid-phase synthesis; sulfamate linker; steroid; inhibitor; 17; beta-HSD; ESTRADIOL-ADENOSINE HYBRIDS; CHEMICAL-SYNTHESIS; BIOLOGICAL EVALUATION; POTENT INHIBITORS; ESTRONE; DESIGN; BREAST; CANCER; DEHYDROGENASE; STEROIDS;
D O I
10.3390/molecules15031590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Combinatorial chemistry is a powerful tool used to rapidly generate a large number of potentially biologically active compounds. In our goal to develop bisubstrate inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1) that interact with both the substrate (estrone or estradiol) and the cofactor (NAD(P) H) binding sites, we used parallel solid-phase synthesis to prepare three libraries of 16 beta-estradiol derivatives with two or three levels of molecular diversity. From estrone, we first synthesized a sulfamate precursor that we loaded on trityl chloride resin using the efficient multidetachable sulfamate linker strategy recently developed in our laboratory. We then introduced molecular diversity [one or two amino acid(s) followed by a carboxylic acid] on steroid nucleus by Fmoc peptide chemistry. Finally, after a nucleophilic cleavage, libraries of 30, 63 and 25 estradiol derivatives were provided. A library of 30 sulfamoylated estradiol derivatives was also generated by acidic cleavage and its members were screened for inhibition of steroid sulfatase. Biological evaluation on homogenated HEK-293 cells overexpressing 17 beta-HSD1 of the estradiol derivatives carrying different oligoamide-type chains at C-16 first revealed that three levels of molecular diversity (a spacer of two amino acids) were necessary to interact with the adenosine part of the cofactor binding site. Second, the best inhibition was obtained when hydrophobic residues (phenylalanine) were used as building blocks.
引用
收藏
页码:1590 / 1631
页数:42
相关论文
共 50 条
  • [41] Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights
    Byrns, Michael C.
    Jin, Yi
    Penning, Trevor M.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (1-2): : 95 - 104
  • [42] Genomic data on breast cancer transcript profile modulation by 17beta-hydroxysteroid dehydrogenase type 1 and 17-beta-estradiol
    Aka, Juliette A.
    Calvo, Ezequiel-Luis
    Lin, Sheng-Xiang
    DATA IN BRIEF, 2016, 9 : 1000 - 1012
  • [43] Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
    Maltais, Rene
    Ayan, Diana
    Trottier, Alexandre
    Barbeau, Xavier
    Laguee, Patrick
    Bouchard, Jean-Emmanuel
    Poirier, Donald
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (01) : 204 - 222
  • [45] Discovery of highly potent, nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors by virtual high-throughput screening
    Starcevic, Stefan
    Turk, Samo
    Brus, Boris
    Cesar, Joko
    Rizner, Tea Lanisnik
    Gobec, Stanislav
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 127 (3-5): : 255 - 261
  • [46] Effect of Free and in Poly(ε-caprolactone) Nanoparticles Incorporated New Type 1 17β-Hydroxysteroid Dehydrogenase Inhibitors on Cancer Cells
    Kocbek, Petra
    Teskac, Karmen
    Brozic, Petra
    Rizner, Tea Lanisnik
    Gobec, Stanislav
    Kristl, Julijana
    CURRENT NANOSCIENCE, 2010, 6 (01) : 69 - 76
  • [47] Bicyclic Substituted Hydroxyphenylmethanones as Novel Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases
    Oster, Alexander
    Hinsberger, Stefan
    Werth, Ruth
    Marchais-Oberwinkler, Sandrine
    Frotscher, Martin
    Hartmann, Rolf W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 8176 - 8186
  • [48] C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17β-hydroxysteroid dehydrogenase:: Chemical synthesis and biological evaluation
    Cadot, Christine
    Laplante, Yannick
    Kamal, Fatima
    Luu-The, Van
    Poirier, Donald
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) : 714 - 726
  • [49] Involvement of up-regulation of 17β-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers
    Miyoshi, Y
    Ando, A
    Shiba, E
    Taguchi, T
    Tamaki, Y
    Noguchi, S
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 685 - 689
  • [50] In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses
    Islam, Md. Rezaul
    Tayyeb, Jehad Zuhair
    Paul, Hridoy Kumar
    Islam, Mirza Nafeul
    Oduselu, Gbolahan Oladipupo
    Bayil, Imren
    Abdellattif, Magda H.
    Al-Ahmary, Khairia Mohammed
    Al-Mhyawi, Saedah R.
    Zaki, Magdi E. A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (15)